Biogen Inc. (BIIB) Q2 2026 Earnings Call July 29, 2026 8:30 AM EDT
Company Participants
Tim Power – Head of Investor Relations
Christopher Viehbacher – President, CEO & Director
Priya Singhal – Executive VP & Head of Development
Robin Kramer – Executive VP & CFO
Alisha Alaimo – President & Head of North America
Conference Call Participants
Christopher Schott – JPMorgan Chase & Co, Research Division
Umer Raffat – Evercore ISI Institutional Equities, Research Division
Marc Goodman – Leerink Partners LLC, Research Division
Salveen Richter – Goldman Sachs Group, Inc., Research Division
Michael Yee – UBS Investment Bank, Research Division
David Amsellem – Piper Sandler & Co., Research Division
Alexandria Hammond – Wolfe Research, LLC
Brian Abrahams – RBC Capital Markets, Research Division
Paul Matteis – Stifel, Nicolaus & Company, Incorporated, Research Division
Evan Seigerman – BMO Capital Markets Equity Research
Terence Flynn – Morgan Stanley, Research Division
Presentation
Operator
Good morning. My name is Jess, and I will be your conference operator today. At this time, I would like to welcome everyone to the Biogen Second Quarter 2026 Earnings Call and Business Update. [Operator Instructions] Today’s conference is being recorded. Thank you.
I would now like to turn the conference over to Mr. Tim Power, Head of Investor Relations. Mr. Power, you may begin your conference.
Tim Power
Head of Investor Relations
Thanks, Jess, and good morning, everyone. Welcome to Biogen’s Second Quarter 2026 Earnings Call. During this call, we will make forward-looking statements, which involve risks and uncertainties that may cause actual results to differ materially from our forward-looking statements. We provide a comprehensive list of risk factors in our SEC filings, which I encourage you to review. Our earnings release and other documents related to our results, as well as reconciliations between GAAP and non-GAAP results discussed on this call can be found in the Investors section of biogen.com. We’ve also posted slides to our website that will be used during
